Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of autism
3.2.1.2 Advancements in diagnostic tools
3.2.1.3 Innovation in therapeutics
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Variability in treatment efficacy
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Drugs
5.2.1 Antipsychotic drugs
5.2.2 Selective serotonin reuptake inhibitors
5.2.3 Stimulants
5.2.4 Other drugs
5.3 Therapy
5.3.1 Behavior and communication therapies
5.3.2 Chelation therapy
5.3.3 Other therapies
5.4 Assistive apps
Chapter 6 Market Estimates and Forecast, By Disease, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Autistic disorder
6.3 Asperger syndrome
6.4 Pervasive developmental disorder (PDD)
6.5 Other diseases
Chapter 7 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Children
7.3 Adult
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Homecare settings
8.4 Rehabilitation centers
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Service Provider
10.1.1 Autism Research Institute
10.1.2 Child Mind Institute, Inc.
10.1.3 Cleveland Clinic
10.1.4 Mayo Foundation for Medical Education and Research (MFMER).
10.1.5 The General Hospital Corporation
10.2 Medication Manufacturer
10.2.1 Axial Therapeutics Inc.
10.2.2 Bristol - Myers Squibb Company
10.2.3 Curemark LLC
10.2.4 Eli Lilly and Company
10.2.5 F. Hoffmann - La Roche Ltd.
10.2.6 Johnson & Johnson Services, Inc.
10.2.7 Novartis AG
10.2.8 Otsuka Pharmaceutical Co., Ltd.
10.2.9 PaxMedica
10.2.10 Pfizer Inc
